Cardiac Ablation Market

Cardiac Ablation Market Size (2024 to 2029)

The global cardiac ablation market size is valued at USD 2.02 Billion in 2024 and is anticipated to reach USD 3.63 Billion by 2029 with a CAGR of 12.45% during the forecast period. 

Cardiac ablation is when heat or cold energy creates tiny scars in the heart to block irregular electrical signals and restore regular heartbeat. Cardiac ablation is used to treat arrhythmias. Mostly, cardiac ablation is done through catheters (thin, flexible tubes) and, in rare cases, performed during cardiac surgery. The disruption in the signaling pathway triggers arrhythmia (irregular heartbeat), which can be treated with medications. Healthcare professionals recommend a cardiac ablation procedure if medications fail in treating arrhythmias.

Market Drivers:

The growing prevalence of cardiac diseases, including cardiac arrhythmias, across the world due to the adoption of a sedentary lifestyle, which includes consumption of alcohol, tobacco, high caffeine intake, and smoking habits, are factors contributing to the occurrences of cardiac diseases. This factor contributes to a rise in the adoption rate of cardiac ablation procedures, impacting global market revenue. According to WHO, over 1.9 million people deaths are recorded each year due to tobacco-related cardiac disorders. The American Heart Association states that cardiovascular ailments account for nearly 800,000 deaths annually in the United States. The growing geriatric population across countries like the US, Western Europe, and Japan is increasing the incidence of cardiovascular diseases, which enhances the adoption of cardiac ablation procedures worldwide by increasing the market revenue. The rising demand for minimally invasive procedures among people due to less recovery time with effective treatment is boosting the global cardiac ablation market growth. The growing awareness among people regarding cardiac problems and the benefits of cardiac ablation over therapeutic and surgical procedures fuels global market growth. The growing market penetration of ablation product manufacturers in developing countries is expected to offer prominent market growth opportunities. 

The growing technological advancements in cardiac ablation procedures were recent developments introducing robotic catheter navigation systems and 3D electro-anatomical mapping systems, creating a wide market for the growth of cardiac ablation technologies market expansion during the forecast period.

The growing investments in research and development activities for enhancing the safety and efficacy of cardiac ablation procedures will augment the global cardiac ablation market growth during the forecast period. The increasing adoption of robotic technologies in ablation techniques is proposing safe and effective cardiac ablation procedures. The increasing introduction of various innovative techniques like balloon-mounted technologies, multi-electrode ablation catheters, and other developments are expected to bolster the global market in the upcoming years. The growing trend of shorter hospital stays and negligible post-surgical issues to recover soon is raising the growth opportunities for the cardiac ablation market in the forecast period.

Market Restraints:

The prominent factor restraining the cardiac ablation market globally is the high risks associated with the ablation procedures. Cardiac ablation risks include bleeding or infection at the site of catheter insertion, blood vessel damage, heart valve damage, new or worsening arrhythmia, the requirement of pacemaker condition, stroke or heart attack, and cases of death in rare scenarios. These possible risk factors with the cardiac ablation procedures are expected to hamper the global market growth. There is a need for more skilled professionals as there are only limited professionals, which is estimated to limit the market expansion. The high costs associated with cardiac treatment procedures are expected to hamper the global market adoption rate as it is difficult to afford for low-income people in developing countries.

The increasingly stringent regulations by the regulatory authorities of different countries regarding the safety and efficacy of the procedures are challenging due to the chances of risks, complexity, and time-consuming process. The presence of alternatives to reduce the arrhythmia condition, either by medications or surgical procedures, may impede the adoption of cardiac ablation procedures, impacting the market revenue.

Impact of the Covid-19 on the Cardiac Ablation Market:

The Pandemic negatively impacted the global cardiac ablation market as the stringent lockdown regulations postponed non-emergency cases due to increased focus on COVID-19 cases. The catheter ablation procedures are typically avoided during the Pandemic to reduce the spread of COVID-19. However, post-pandemic increased the demand for cardiac ablation procedures due to increased cases of atrial fibrillation, which enhanced the market revenue. The demand is expected to stay intact during the forecast period due to growing cardiovascular problems.

REPORT COVERAGE:

This research report on the cardiac ablation market has been segmented and sub-segmented based on the technology, approach, application, end-use, and region.

By Technology:

• Radiofrequency Ablation
• Cryoablation
• Ultrasound Ablation
• Electrical Ablation 
• Others

The radiofrequency ablation segment held the largest market share of 56% in the global cardiac ablation market in 2023. The radiofrequency ablation technique is affordable compared to other ablation techniques, combined with high safety, efficacy, and shorter procedure duration, all of which boost the global market revenue in this segment. Radiofrequency ablation is widely used in cancer treatment, atrial fibrillation, and pain management, and it is projected that the segment will witness lucrative growth during the forecast period. 

The cryptoablation segment is estimated to grow significantly during the forecast period due to rapid regulatory approvals and a widening adoption rate. Cryoablation therapy is gaining traction from the recent period to its successful clinical trials. This procedure was first done on breast cancer patients in the US, Japan, and European countries, which had shown remarkable outcomes. The US Food and Drug Administration approved this technique for treating kidney, liver, and other cancerous body areas.

By Approach:

• Catheter-based
• Open/Surgical

The catheter-based segment held the largest share of global cardiac ablation market revenue in 2023 due to the wide usage of catheters for ablation techniques, which are minimally invasive and have shorter recovery periods. 

The open/surgical segment is expected to grow significantly during the forecast period. These procedures are used to treat atrial fibrillation and other cardiovascular diseases. According to the Heart and Stroke Foundation, approximately 25% of stroke cases are after years of age due to atrial fibrillation, whose occurrence is at high chances. The rising prevalence of cardiovascular diseases is expected to boost the open/surgical segment growth in the forecast period. 

By Application:

• Atrial Fibrillation
• Ventricular Tachycardia
• Others

The atrial fibrillation segment dominated the global market revenue with the most significant share in 2023 due to growing cases of atrial fibrillation worldwide. The increasing prevalence of cardiac diseases inducing atrial fibrillation drives the segment growth. According to the Centers for Disease Control and Prevention, approximately 2 percent of people younger than 65 years have Atrial Fibrillation, and about 9 percent of people aged 65 and older have it. These scenarios are expected to have prominent growth during the forecast period. 

The tachycardia segment is expected to record significant growth with the highest CAGR during the forecast period due to the increasing number of patients suffering from tachycardia, which has risen considerably in recent years. According to the Centers for Disease and Control, tachycardia affects nearly 1 in every 300 people in the US. The tachycardia condition is mainly occurring amongst the elderly and female population. 

By End-Use:

• Hospitals
• Ambulatory Surgical Centers
• Cardiac Centers
• Others

The hospitals segment dominated the global market with the largest share and is expected to maintain the domination during the forecast period due to the presence of skilled professionals with advanced technological equipment; patients prefer hospitals to clinics. 

Cardiac centers have gained traction in recent periods due to the increasing number of centers across developing countries as they are offering advanced treatment alternatives. The necessity of advanced treatment solutions is enhancing the adoption of these cardiac centers. These cardiac centers offer preliminary care and adequate treatment to patients undergoing cardiac ablation procedures, which augments the segment growth. 

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

The North American region dominated the global cardiac ablation market in 2023, with a significant share of 37% due to growing cardiac problems. The presence of significant market players and the advanced technological adoption in healthcare boosts the market growth in the region. The increasing product approvals and growing investments in R&D to develop effective methods are expected to fuel market revenue growth. The demand for cardiac ablation techniques is high in the US due to the country's massive number of heart patients. Various studies stated that cardiac arrest is the leading cause of death in the US.

Asia Pacific region is projected to grow significantly, with the highest CAGR in the forecast period. The increasing cases of atrial fibrillation and growing healthcare expenditure across the region, with substantial investments by the market players, are boosting the regional market growth. Due to the increasing incidence of cancer and cardiac conditions and technological advancements in ablation products, the regional market is expected to grow significantly during the forecast period. 

Key Market Players:

Abbott Laboratories, Medtronic, Biosense Webster (Johnson & Johnson), Angiodynamics, Boston Scientific Corporation, Atricure, Olympus Corporation, St Jude Medical Inc., and Alcon Laboratories are some of the key market players in the cardiac ablation market.

 Recent Market Developments:

• In August 2022, Medtronic, a global leader in healthcare technology, acquired Affera, Inc. The acquisition is expected to increase the company's cardiac ablation portfolio by including the first ever cardiac mapping and navigation platform, which includes distinct, completely integrated diagnostic, focused pulsed field, and radiofrequency ablation solution. 
• In September 2022, Biosense Webster, Inc., part of Johnson & Johnson MedTech, launched the OCTARAY Mapping Catheter with TRUEref Technology powered by CARTO 3 Version 7 System. The OCTARAYTM Mapping Catheter is designed for mapping cardiac arrhythmias like atrial fibrillation.